Literature DB >> 28533400

The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.

Isa Murrell1, Carmen Bedford1, Kristin Ladell1, Kelly L Miners1, David A Price1, Peter Tomasec1, Gavin W G Wilkinson1, Richard J Stanton2.   

Abstract

Human cytomegalovirus (HCMV) strains that have been passaged in vitro rapidly acquire mutations that impact viral growth. These laboratory-adapted strains of HCMV generally exhibit restricted tropism, produce high levels of cell-free virus, and develop susceptibility to natural killer cells. To permit experimentation with a virus that retained a clinically relevant phenotype, we reconstructed a wild-type (WT) HCMV genome using bacterial artificial chromosome technology. Like clinical virus, this genome proved to be unstable in cell culture; however, propagation of intact virus was achieved by placing the RL13 and UL128 genes under conditional expression. In this study, we show that WT-HCMV produces extremely low titers of cell-free virus but can efficiently infect fibroblasts, epithelial, monocyte-derived dendritic, and Langerhans cells via direct cell-cell transmission. This process of cell-cell transfer required the UL128 locus, but not the RL13 gene, and was significantly less vulnerable to the disruptive effects of IFN, cellular restriction factors, and neutralizing antibodies compared with cell-free entry. Resistance to neutralizing antibodies was dependent on high-level expression of the pentameric gH/gL/gpUL128-131A complex, a feature of WT but not passaged strains of HCMV.

Entities:  

Keywords:  HCMV; cell–cell spread; herpesvirus; immune evasion; virology

Mesh:

Substances:

Year:  2017        PMID: 28533400      PMCID: PMC5468625          DOI: 10.1073/pnas.1704809114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  81 in total

1.  Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells.

Authors:  W J Waldman; J M Sneddon; R E Stephens; W H Roberts
Journal:  J Med Virol       Date:  1989-08       Impact factor: 2.327

2.  Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1.

Authors:  A J Davis; P Li; C J Burrell
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

3.  Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Authors:  Daniele Lilleri; Anna Kabanova; Antonio Lanzavecchia; Giuseppe Gerna
Journal:  J Clin Immunol       Date:  2012-07-27       Impact factor: 8.317

4.  Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.

Authors:  Yingxia Wen; James Monroe; Christine Linton; Jacob Archer; Clayton W Beard; Susan W Barnett; Giuseppe Palladino; Peter W Mason; Andrea Carfi; Anders E Lilja
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

5.  Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Authors:  Irene A Abela; Livia Berlinger; Merle Schanz; Lucy Reynell; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

6.  HCMV spread and cell tropism are determined by distinct virus populations.

Authors:  Laura Scrivano; Christian Sinzger; Hans Nitschko; Ulrich H Koszinowski; Barbara Adler
Journal:  PLoS Pathog       Date:  2011-01-13       Impact factor: 6.823

7.  Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.

Authors:  Wendell Smith; Peter Tomasec; Rebecca Aicheler; Andrea Loewendorf; Ivana Nemčovičová; Eddie C Y Wang; Richard J Stanton; Matt Macauley; Paula Norris; Laure Willen; Eva Ruckova; Akio Nomoto; Pascal Schneider; Gabriele Hahn; Dirk M Zajonc; Carl F Ware; Gavin W G Wilkinson; Chris A Benedict
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

8.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.

Authors:  Marine Malbec; Françoise Porrot; Rejane Rua; Joshua Horwitz; Florian Klein; Ari Halper-Stromberg; Johannes F Scheid; Caroline Eden; Hugo Mouquet; Michel C Nussenzweig; Olivier Schwartz
Journal:  J Exp Med       Date:  2013-11-25       Impact factor: 14.307

9.  Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.

Authors:  Katie Caviness; Farah Bughio; Lindsey B Crawford; Daniel N Streblow; Jay A Nelson; Patrizia Caposio; Felicia Goodrum
Journal:  mBio       Date:  2016-03-01       Impact factor: 7.867

10.  Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.

Authors:  Song Hee Lee; Emily R Albright; Jeong-Hee Lee; Derek Jacobs; Robert F Kalejta
Journal:  Sci Adv       Date:  2015-11-27       Impact factor: 14.136

View more
  51 in total

1.  A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2021-03-17       Impact factor: 3.891

2.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Role of PDGF receptor-α during human cytomegalovirus entry into fibroblasts.

Authors:  Kai Wu; Adam Oberstein; Wei Wang; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

4.  Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.

Authors:  William J Britt
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

5.  Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

Authors:  Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

6.  Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV.

Authors:  Sebastian J Theobald; Christoph Kreer; Sahamoddin Khailaie; Agnes Bonifacius; Britta Eiz-Vesper; Constanca Figueiredo; Michael Mach; Marija Backovic; Matthias Ballmaier; Johannes Koenig; Henning Olbrich; Andreas Schneider; Valery Volk; Simon Danisch; Lutz Gieselmann; Meryem Seda Ercanoglu; Martin Messerle; Constantin von Kaisenberg; Torsten Witte; Frank Klawonn; Michael Meyer-Hermann; Florian Klein; Renata Stripecke
Journal:  PLoS Pathog       Date:  2020-07-15       Impact factor: 6.823

7.  Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.

Authors:  Zeguang Wu; Ruifang Qin; Li Wang; Matteo Bosso; Myriam Scherer; Thomas Stamminger; Dominik Hotter; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

8.  Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.

Authors:  Le Zhang Day; Cora Stegmann; Eric P Schultz; Jean-Marc Lanchy; Qin Yu; Brent J Ryckman
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

9.  Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2020-02-18       Impact factor: 3.891

10.  Human Cytomegalovirus Tropism Modulator UL148 Interacts with SEL1L, a Cellular Factor That Governs Endoplasmic Reticulum-Associated Degradation of the Viral Envelope Glycoprotein gO.

Authors:  Christopher C Nguyen; Mohammed N A Siddiquey; Hongbo Zhang; Gang Li; Jeremy P Kamil
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.